Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Disodium edetate (37.5mg) Injection
Therapeutic Category
Anticoagulant, Cardiology
Dosage Form
Injection
Packaging Type
Vial
Packaging
mono
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Disodium Edetate 37.5 mg Injection is a chelating agent used in the management of heavy metal poisoning and certain calcium-related conditions. It helps in binding toxic metals in the bloodstream and facilitates their removal from the body.
Disodium Edetate works by forming stable complexes with metal ions such as lead and calcium, reducing their harmful effects and aiding in safe elimination through the kidneys.
This injection is primarily used in hospital and critical care settings under medical supervision. It plays an important role in emergency treatment protocols involving metal toxicity and electrolyte imbalances.
Common side effects may include fever, headache, nausea, vomiting, diarrhea, and infusion-related reactions such as rash or flushing. Some patients may experience elevated liver enzymes. Rarely, hypersensitivity reactions or severe allergic responses may occur.
Disodium Edetate 37.5mg Injection is indicated for the treatment of serious fungal infections such as invasive candidiasis, esophageal candidiasis, and invasive aspergillosis, particularly in patients who are refractory to or intolerant of other antifungal therapies. It works by inhibiting the synthesis of the fungal cell wall, thereby controlling and eliminating infection.
This medication should be administered under strict medical supervision. Regular monitoring of liver function is recommended during treatment. Inform your doctor about any history of liver disease, allergies, or ongoing medications. Complete the full prescribed course for effective results.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep in original packaging and out of reach of children. Use as directed after reconstitution.
Composition : Ondansetron (2mg) Injection
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Cefoperazone (1000mg) + Sulbactam (500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefoperazone (500mg) + Sulbactam (500mg)
Composition : Cerebroprotein Hydrolysate (60mg)
Composition : Cisplatin (50mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ditate 37.5 Injection, containing Disodium Edetate 37.5mg, has demand in hospital emergency and supportive care segments, making it a niche but useful product for medical distributors, wholesalers, and pharma franchise partners focusing on critical care and detoxification-support portfolios.
Medical distributors and agencies can benefit from its use in specific clinical conditions where chelating agents are required, including heavy metal toxicity management and supportive hospital care protocols. Ditate 37.5 Injection helps strengthen a specialized critical care injectable product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ditate 37.5 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from reliable product availability, business margins, and access to a specialized hospital-use injectable range when partnering for Ditate 37.5 Injection distribution.
Medical distributors, stockists, and wholesalers interested in Ditate 37.5 Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.